Tight binding inhibitors--IX. Kinetic parameters of dihydrofolate reductase inhibited by methotrexate, an example of equilibrium study

Synthesis of carbocyclic orotidine analogs as potential orotidine decarboxylase inhibitors.

Nucleosides, nucleotides & nucleic acids·2002

Enhancement of the bioavailability of oral uridine by coadministration of 5-(phenylthio)acyclouridine, a uridine phosphorylase inhibitor: implications for uridine rescue regimens in chemotherapy.

Cancer chemotherapy and pharmacology·2002

Modulation of the pharmacokinetics of endogenous plasma uridine by 5-(phenylthio)acyclouridine, a uridine phosphorylase inhibitor: implications for chemotherapy.

Cancer chemotherapy and pharmacology·2001

Effect of 5-(phenylselenenyl)acyclouridine, an inhibitor of uridine phosphorylase, on plasma concentration of uridine released from 2',3',5'-tri-O-acetyluridine, a prodrug of uridine: relevance to uridine rescue in chemotherapy.

Cancer chemotherapy and pharmacology·2000

5-phenylthioacyclouridine: a potent and specific inhibitor of uridine phosphorylase.

Biochemical pharmacology·2000

Effect of administration of 5-(phenylselenenyl)acyclouridine, an inhibitor of uridine phosphorylase, on the anti-tumor efficacy of 5-fluoro-2'-deoxyuridine against murine colon tumor C26-10.

Biochemical pharmacology·2000

Antibody-drug conjugates as promising platform for intrahepatic cholangiocarcinoma: molecular insights, drug-delivery challenges, and emerging therapeutic targets.

Biochemical pharmacology·2026

Ubiquitin-Like protein UBL1 orchestrates monocyte recruitment and pro-inflammatory macrophage activation in critical limb ischemia: Involving SUMOylation and stabilization of PER1.

Biochemical pharmacology·2026

Basis of the IgM cleavage activity of IgMDELsp and IgMDEMma.

Biochemical pharmacology·2026

Conformational allocation of mitofusin 2 in neuronal mitochondrial dynamics: Mechanisms and therapeutic targeting.

Biochemical pharmacology·2026

Intaermedin attenuates chronic intermittent hypoxia-induced renal fibrosis via SIRT1-mediated inhibition of the NOX4/ROS axis.

Biochemical pharmacology·2026

Protein degraders targeting JAK/STAT3 signaling pathway are emerging therapeutic modalities for human cancers.

Biochemical pharmacology·2026

Serum vs. Dietary Magnesium and Cardiometabolic Outcomes in Saudi Adolescents.

Nutrients·2026

Transcriptomic Profiling of Sea Buckthorn (Hippophae rhamnoides L.) Juice Intervention in 3D hAESC Spheroids: Implications for Cellular Plasticity and Tissue Regeneration.

Nutrients·2026

Multi-Omics Analysis Reveals the Potential Role of Inonotus obliquus in Mit-Igating Hemolytic Jaundice.

Nutrients·2026

Nutritional Modulation of the Immuno-Biomineral Interface: From Vascular Calcification to a Hypothesis-Generating Framework for Tumor-Associated Biomineralization.

Nutrients·2026

Iron Chelation Therapy in Iron Overload Disorders: A Systematic Review with Narrative Synthesis of Bioenergetic Dysfunction, Oxidative Stress, and Biomarker-Guided Management.

International journal of molecular sciences·2026

Metagenomic and Metabolomic Signatures of Gut Microbiota After Helicobacter pylori Eradication Therapy Supplemented with Butyric Acid and Inulin: Observational Study.

International journal of molecular sciences·2026

Related Experiment Videos

Tight binding inhibitors--IX. Kinetic parameters of dihydrofolate reductase inhibited by methotrexate, an example of

Related Concept Videos

Synthesis of carbocyclic orotidine analogs as potential orotidine decarboxylase inhibitors.

Enhancement of the bioavailability of oral uridine by coadministration of 5-(phenylthio)acyclouridine, a uridine phosphorylase inhibitor: implications for uridine rescue regimens in chemotherapy.

Modulation of the pharmacokinetics of endogenous plasma uridine by 5-(phenylthio)acyclouridine, a uridine phosphorylase inhibitor: implications for chemotherapy.

Effect of 5-(phenylselenenyl)acyclouridine, an inhibitor of uridine phosphorylase, on plasma concentration of uridine released from 2',3',5'-tri-O-acetyluridine, a prodrug of uridine: relevance to uridine rescue in chemotherapy.

5-phenylthioacyclouridine: a potent and specific inhibitor of uridine phosphorylase.

Effect of administration of 5-(phenylselenenyl)acyclouridine, an inhibitor of uridine phosphorylase, on the anti-tumor efficacy of 5-fluoro-2'-deoxyuridine against murine colon tumor C26-10.

Antibody-drug conjugates as promising platform for intrahepatic cholangiocarcinoma: molecular insights, drug-delivery challenges, and emerging therapeutic targets.

Ubiquitin-Like protein UBL1 orchestrates monocyte recruitment and pro-inflammatory macrophage activation in critical limb ischemia: Involving SUMOylation and stabilization of PER1.

Basis of the IgM cleavage activity of IgMDELsp and IgMDEMma.

Conformational allocation of mitofusin 2 in neuronal mitochondrial dynamics: Mechanisms and therapeutic targeting.

Intaermedin attenuates chronic intermittent hypoxia-induced renal fibrosis via SIRT1-mediated inhibition of the NOX4/ROS axis.

Protein degraders targeting JAK/STAT3 signaling pathway are emerging therapeutic modalities for human cancers.

Serum vs. Dietary Magnesium and Cardiometabolic Outcomes in Saudi Adolescents.

Transcriptomic Profiling of Sea Buckthorn (Hippophae rhamnoides L.) Juice Intervention in 3D hAESC Spheroids: Implications for Cellular Plasticity and Tissue Regeneration.

Multi-Omics Analysis Reveals the Potential Role of Inonotus obliquus in Mit-Igating Hemolytic Jaundice.

Nutritional Modulation of the Immuno-Biomineral Interface: From Vascular Calcification to a Hypothesis-Generating Framework for Tumor-Associated Biomineralization.

Iron Chelation Therapy in Iron Overload Disorders: A Systematic Review with Narrative Synthesis of Bioenergetic Dysfunction, Oxidative Stress, and Biomarker-Guided Management.

Metagenomic and Metabolomic Signatures of Gut Microbiota After Helicobacter pylori Eradication Therapy Supplemented with Butyric Acid and Inulin: Observational Study.

Related Experiment Videos

Tight binding inhibitors--IX. Kinetic parameters of dihydrofolate reductase inhibited by methotrexate, an example of...

Related Concept Videos

Related Articles

Tight binding inhibitors--IX. Kinetic parameters of dihydrofolate reductase inhibited by methotrexate, an example of